Woodward Diversified Capital’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$769K Sell
31,933
-33
-0.1% -$863 0.34% 72
2026
Q1
$881K Buy
31,966
+1,794
+6% +$47.8K 0.4% 60
2025
Q4
$751K Buy
30,172
+623
+2% +$15.7K 0.34% 74
2025
Q3
$753K Buy
29,549
+494
+2% +$12.2K 0.35% 78
2025
Q2
$704K Buy
29,055
+12,491
+75% +$291K 0.36% 74
2025
Q1
$420K Buy
16,564
+1,082
+7% +$28.3K 0.3% 82
2024
Q4
$411K Sell
15,482
-7,517
-33% -$204K 0.3% 75
2024
Q3
$666K Sell
22,999
-17,087
-43% -$498K 0.42% 69
2024
Q2
$1.12M Sell
40,086
-3,969
-9% -$109K 0.66% 37
2024
Q1
$1.22M Buy
44,055
+2,370
+6% +$65.8K 0.76% 32
2023
Q4
$1.2M Buy
41,685
+215
+0.5% +$6.5K 0.75% 31
2023
Q3
$1.38M Buy
41,470
+4,396
+12% +$155K 0.99% 19
2023
Q2
$1.36M Buy
37,074
+197
+0.5% +$7.67K 1.03% 21
2023
Q1
$1.5M Buy
36,877
+433
+1% +$18.7K 1.18% 14
2022
Q4
$1.87M Buy
36,444
+373
+1% +$17.9K 1.5% 10
2022
Q3
$1.58M Sell
36,071
-3,059
-8% -$149K 1.3% 14
2022
Q2
$2.05M Buy
39,130
+257
+0.7% +$13.1K 1.57% 13
2022
Q1
$2.01M Buy
38,873
+1,485
+4% +$77K 1.32% 13
2021
Q4
$2.21M Buy
37,388
+3,875
+12% +$192K 1.3% 11
2021
Q3
$1.44M Buy
33,513
+676
+2% +$29.9K 0.9% 22
2021
Q2
$1.29M Sell
32,837
-2,020
-6% -$78.6K 0.73% 35
2021
Q1
$1.26M Sell
34,857
-488
-1% -$17.3K 0.74% 35
2020
Q4
$1.3M Buy
+35,345
New +$1.3M 0.84% 32

Other funds holding PFE

Woodward Diversified Capital's PFE Position: Q2 2026 in Review

Woodward Diversified Capital reduced its Pfizer (PFE) stake by 0.1% in Q2 2026, selling an estimated $863 and leaving 31,933 shares worth $769K. The position accounts for 0.34% of the portfolio, ranked #72.

Woodward Diversified Capital first reported a position in PFE in Q4 2020 and has held it in 23 quarters since. The position peaked at $2.21M in Q4 2021. 1,338 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Woodward Diversified Capital held 31,933 shares of Pfizer worth $769K as of Q2 2026.
  • Woodward Diversified Capital sold 33 Pfizer shares in Q2 2026, an estimated $863.
  • Pfizer made up 0.34% of Woodward Diversified Capital's portfolio in Q2 2026, its #72 holding.
  • Woodward Diversified Capital first reported a position in Pfizer in Q4 2020 and has held it in 23 quarters since.
  • Woodward Diversified Capital's Pfizer position peaked at $2.21M in Q4 2021.
  • 1,338 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Woodward Diversified Capital's 13F filing for Q2 2026, filed 28 Jul 2026.